Genvinset® HFE H63D

Kit for detecting the H63D mutation of HFE gene by Real Time PCR using TaqMan® probes technology

Information about the product

Hereditary hemochromatosis (HH) is an autosomal recessive inherited disorder of iron metabolism. Due to excessive intestinal absorption, iron accumulates in the parenchymal cells of the liver, pancreas, heart and other organs resulting in damage to its structure and its function impaired. Although the disease symptoms are often non-specific, much of the organ damage is irreversible once it has occurred. Early detection and treatment are therefore very important as part of preventive medicine.

A number of different HFE mutations have been described. One of these mutations is a substitution at position 187 (C -> G), detected with a relatively high frequency in exon 2 of the HFE gene wherein the amino acid histidine is replaced by an aspartic acid at position 63 (H63D). The contribution of this allele for iron overload is most relevant in the case of heterozygosity combined with allele C282Y (C282Y/H63D).

Intended use

Genvinset® HFE H63D is a semi-automated in vitro diagnostic kit for the qualitative detection of the H63D mutation (NCBI dbSNP rs1799945; NM_000410.4:c.187C>G), in the HFE gene (OMIM: 613609) associated with hereditary hemochromatosis, in genomic DNA extracted from whole blood using Real Time PCR technology with specific TaqMan® probes.

Patients who can benefit from this determination are those referred by a specialist. The results of this test should not be the only ones on which the therapeutic decision is based and should be used as an aid in the diagnosis together with results of other markers of the disease.

The intended user of the kit is technical personnel trained to carry out the protocol and the interpretation of results described in the instructions for use.

Workflow

Results

Limitations

• Mutations or polymorphisms at annealing primer/probe sites are possible and may result in the lack of allele definition. Other technologies could be necessary to resolve the typing.
• Data and result interpretation should be revised by qualified personnel.
• This product is an auxiliary tool for the diagnosis of patients with suspected hereditary hemochromatosis. Use these results in conjunction with clinical data and results of other tests